Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CYM-5541 (ML249) 是一种选择性的S1P3受体变构激动剂,EC50值在72至132 nM 之间。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 247 | 现货 | ||
2 mg | ¥ 353 | 现货 | ||
5 mg | ¥ 596 | 现货 | ||
10 mg | ¥ 986 | 现货 | ||
25 mg | ¥ 1,890 | 现货 | ||
50 mg | ¥ 2,790 | 现货 | ||
100 mg | ¥ 3,970 | 现货 | ||
500 mg | ¥ 8,680 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 657 | 现货 |
产品描述 | CYM-5541 (ML249) is a selective and allosteric S1P3 receptor agonist. |
靶点活性 | S1P3:72-132 nM(EC50) |
体外活性 | CYM-5541 is a full agonist, able to reach the maximum level of ERK phosphorylation that is observed with S1P. CYM-5541 has an EC50 of between 72 and 132 nM and exhibits exquisite selectivity over other S1P receptor subtypes: S1P1 EC50>10 μM, S1P2 EC50>50 μM, S1P4 EC50>50 μM, and S1P5 EC50>25 μM. CYM-5541 also shows selectivity over a large panel of protein targets, with no significant activities, in the Ricerca profiling panel of 55 GPCRs, ion channels, and transporters. CYM-5541 allowed us to identify an allosteric site where F263 is a key gate-keeper residue for its affinity and efficacy. The novel allosteric hydrophobic pocket may account for the S1P3 selectivity of CYM-5541[1]. |
激酶实验 | Jump-In TI CHO-K cells stably expressing WT or mutant S1P3 are serum-starved for 4 hrs. They are then incubated at 4 °C for 30 min in the binding buffer containing 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 15 mM NaF, 0.5 mM EDTA, 1 mM Na3VO4, 0.5% fatty acid-free bovine serum albumin, and protease inhibitor mixture with 0.1 nM [33P]S1P and increasing concentrations of S1P, SPM-242, or CYM-5541. Cells are washed three times with cold binding buffer. Cell-bound radioactivity is measured by lysing the cells with 0.5% SDS followed by liquid scintillation counting. The raw data is normalized so that the level of [33P]S1P bound to each cell line (WT or mutant) in the absence of competing ligand is referenced as 100% for its own cell line[1]. |
别名 | CYM 5541, ML249, CID-17253208 |
分子量 | 316.44 |
分子式 | C19H28N2O2 |
CAS No. | 945128-26-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (158.01 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.1602 mL | 15.8008 mL | 31.6016 mL | 79.0039 mL |
5 mM | 0.632 mL | 3.1602 mL | 6.3203 mL | 15.8008 mL | |
10 mM | 0.316 mL | 1.5801 mL | 3.1602 mL | 7.9004 mL | |
20 mM | 0.158 mL | 0.79 mL | 1.5801 mL | 3.9502 mL | |
50 mM | 0.0632 mL | 0.316 mL | 0.632 mL | 1.5801 mL | |
100 mM | 0.0316 mL | 0.158 mL | 0.316 mL | 0.79 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CYM-5541 945128-26-7 GPCR/G Protein S1P Receptor LPL Receptor CYM 5541 inhibit ML249 CID 17253208 ML-249 CID17253208 CID-17253208 Inhibitor Lysophospholipid Receptor CYM5541 ML 249 inhibitor